Epidermolysis bullosa acquisita associated with psoriasis. 2010

Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004890 Erythema Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. Erythemas
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
September 2007, Clinical and experimental dermatology,
Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
November 1997, The British journal of dermatology,
Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
November 1987, Journal of the American Academy of Dermatology,
Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
January 2015, European journal of dermatology : EJD,
Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
July 1988, The British journal of dermatology,
Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
October 2010, Presse medicale (Paris, France : 1983),
Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
November 1994, The British journal of dermatology,
Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
January 1989, Indian journal of dermatology, venereology and leprology,
Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
August 1988, The American Journal of dermatopathology,
Rieko Kabashima, and Ryosuke Hino, and Toshinori Bito, and Kenji Kabashima, and Motonobu Nakamura, and Oyama Bungo, and Takashi Hashimoto, and Yoshiki Tokura
October 2013, Journal of the European Academy of Dermatology and Venereology : JEADV,
Copied contents to your clipboard!